MetaSafe Strengthens the Team

We are delighted to announce the appointment of our new team member Dr. Magnus Halldin. Magnus is now appointed as Scientific Advisor for MetaSafe in the DMPK (ADME) area in which Magnus possesses 30 years of experience.
Magnus has a Master’s degree in Pharmacy from School of Pharmacy, University of Uppsala, Uppsala 1977 and a PhD in Pharmacognosy (Thesis: Biotransformation of Tetrahydrocannabinol in Man and Animal) from University of Uppsala, 1982.
After postdoctoral studies at School of Pharmacy, University of California, San Francisco, USA, Magnus Halldin joined Astra (AstraZeneca) in 1985, where he up to 2013 held various line, project and scientific management positions in the company. Magnus also had a scientific DMPK advisory role on numerous global scientific committees and knowledge groups, and in-licensing and due diligence opportunities within both Discovery and Development.
His appointment is a valuable addition to the team and a perfect complement to our analytical service within the DMPK area in both discovery and development.


MetaSafe “3 years later” in Swedish newspaper “Svenska Dagbladet” 5th of November